Bond Biosciences, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-10-05.
Bond Biosciences, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 5, 2026. The filing reports $7.61M sold. Its industry group is Other Health Care. It names Michael Beckloff (Director), Cory Berkland (Executive Officer, Director), Timothy Opler (Director) (SEC Form D/A, October 5, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Bond Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Bond Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Bond Biosciences, Inc., from the filings we hold.
Collage Venture Partners, LLC received sales compensation on this raise and on 7 other raises we hold, nearest in date first:
Other Health Care raises filed within 90 days of this one, largest first.
Get an email when Bond Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Bond Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Bond Biosciences, Inc. →Get the full cited report on Bond Biosciences, Inc.
What the filing shows about Bond Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Bond Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Bond Biosciences, Inc.'s address as 170 English Landing Drive, Suite 201B, Parkville, MO 64152.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Bond Biosciences, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Bond Biosciences, Inc. is a registered filer with the SEC (CIK 1824224) and has filed since 2024-09-06. 2 filings are on record, the latest on 2026-04-08.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Bond Biosciences, Inc.'s Form D of 2026-10-05 names Michael Beckloff, Cory Berkland, Timothy Opler and 2 more as its officers, directors or promoters.
Its new offerings report $7.97M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $7.61M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract to treat or prevent disease.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Michael Beckloff is named as Director on the Form D that Bond Biosciences, Inc. filed with the SEC on 5 October 2026, one of 5 people that filing names.
Cory Berkland is named as Executive Officer and Director on the Form D that Bond Biosciences, Inc. filed with the SEC on 5 October 2026, one of 5 people that filing names.
Timothy Opler is named as Director on the Form D that Bond Biosciences, Inc. filed with the SEC on 5 October 2026, one of 5 people that filing names.
Michael Riley is named as Executive Officer and Director on the Form D that Bond Biosciences, Inc. filed with the SEC on 5 October 2026, one of 5 people that filing names.
Jay Shepard is named as Director on the Form D that Bond Biosciences, Inc. filed with the SEC on 5 October 2026, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2026-10-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Bond Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Bond Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bond Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Bond Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Bond Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-06 (bond.bio).
Each opens in a new tab, filled in for Bond Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/bond-biosciences-inc-form-d-000053